Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Daiwa Capital Upgrades Merck & Co to Outperform, Raises Price Target to $102

Daiwa Capital analyst Narumi Nakagiri upgrades Merck & Co (NYSE:MRK) from Hold to Outperform and raises the price target from $89 to $102.
byBenzinga Newsdesk
July 7, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Daiwa Capital analyst Narumi Nakagiri upgrades Merck & Co (NYSE:MRK) from Hold to Outperform and raises the price target from $89 to $102.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts